drugset / Trial / NCT05434897
A Study to Evaluate the Safety, Tolerability and Efficacy of AK3280 Cream on Hypertrophic Scar
RandomizedParallel-groupTriple-blindTreatment
Summary
A randomized, double-blind, placebo self-controlled phase I/II clinical study to evaluate the safety, tolerability and preventive efficacy of different doses of AK3280 cream （AK3287 ） after cicatrectomy in Patients with Hypertrophic Scar in China.
Timeline
- Start
- 2022-07-08
- Primary completion
- 2023-07-18
- Completion
- 2023-07-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AK3280 | Unknown | 2 % | Other |
| Subject | AK3280 | Unknown | 4 % | Other |
| Subject | AK3280 | Unknown | 8 % | Other |